AUTHORS:

Chrabąszcz K., Kossowski-Kołodziej T., Panek A., Pogoda K.

ABSTRACT:

Understanding lipid metabolism in peripheral glial cells is crucial for elucidating the molecular mechanisms underlying neurodegeneration, cancerogenesis and therapy resistance. Here, we introduce a spectrolipidomic sensing approach that integrates Raman, FT-IR, and AFM-IR spectroscopy to monitor nanoscale cholesterol remodeling in glial cells exposed to cannabidiol (CBD). Deuterated cholesterol (dChol) was employed as an intrinsic, spectroscopically active molecular probe, enabling selective tracking of cholesterol transformations through characteristic Csingle bondD vibrational signatures within the 2300–2000 cm−1 silent spectral region. Multimodal vibrational spectroscopy provided label-free, spatially resolved insight into lipid organization, redistribution, and metabolic reprogramming across micro- and nanoscales. The dChol probe enabled semiquantitative evaluation of cholesterol uptake, esterification, and membrane integration, revealing that the sequence of CBD exposure, before or after probe addition, triggers distinct lipid metabolic pathways. Raman spectroscopy demonstrated superior sensitivity, with reliable detection of intracellular dChol at concentrations as low as 10 μM, outperforming FT-IR imaging and confirming its suitability for cell lipid sensing. This analytical platform establishes deuterium-labeled lipids as powerful vibrational sensors for probing lipid metabolism and CBD-induced remodeling in situ. The presented spectrolipidomic framework paves the way for next-generation, spectroscopy-based biosensing systems capable of visualizing lipid dynamics, membrane restructuring, and drug–lipid interactions under pharmacological or environmental stress conditions.

Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2026, vol. 359, art. 127947, doi: 10.1016/j.saa.2026.127947